New classification for identifying HR myeloma based on cytogenetic abnormalities
Dr Veronesi talks to ecancer at The Umberto Veronesi Milan Breast Cancer Conference about the conference aims to provide caregivers and scientists interested in breast cancer with results of current research and innovations that enhance patient care and understanding of the disease.
Read more about the founding editor of the Milan Breast Cancer Conference and co-founder of ecancer, Umberto Veronesi, here.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Gaza's cancer patients: Navigating the dual struggle of illness and war
Tele-mentoring: Impact of project ECHO
SABCS 2023: Latest breast cancer diagnostics guidelines
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam
The Southeast Asian Breast Cancer Symposium; background, aims and successes
The use of IORT at Universitätsmedizin Mannheim hospital
Choosing Wisely to mitigate financial toxicity in cancer care in Africa